TrialJournal of gastroenterology and hepatology2026
Dose Reduction of Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients With Complete Biochemical Response: An Open-Label Randomized Clinical Trial.
Chengmei He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.